Teva Pharmaceutical Industries Ltd (TEVA) Stock Price, Quote, News & History

TEVANYSE
$34.23
0.070.20%
Last update: May 22, 11:47 AM

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
1.71B
Investing Cash Flow (TTM)
765.00M
Financing Cash Flow (TTM)
-394.00M
Free Cash Flow (TTM)
1.17B
Capital Expenditure (TTM)
-542.00M
Net Change in Cash (TTM)
2.09B

Analyst Trends and Forecast

2
Feb
1
Mar
5
Apr
1
May
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
3.5
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$53.43B
PE Ratio (TTM)
25.49
PE Ratio (FWD)
12.53
PEG Ratio (TTM)
1.41
PS Ratio (TTM)
2.30
PB Ratio (TTM)
4.83
Earnings Yield % (TTM)
3.92%
Earnings Yield % (FWD)
7.98%
EV / EBITDA (TTM)
16.35
Price / EBITDA (TTM)
12.21
Price / Free Cash Flow (TTM)
34.04
Book Value / Share
$7.07

Company Debt

Total Debt
$16.63B
LT Debt
$14.02B
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-$2.77B
Total Cash
$3.74B
Debt to Equity
2.05
Issuance of Debt (TTM)
-$469.00M
Repayment of Debt (TTM)
-$2.77B

Key Statistics

Open
$34.29
Close
-
Volume / Avg.
1.07M / 6.68M
Day Range
$34.19 - $34.85
52 Wk Range
14.99 - 37.35
Market Cap
$39.86B
P/E Ratio
25.49
Dividend Yield
-
Exchange
NYSE
RSI
52
Short Interest
2.69%
Days to Cover
4

About

Sector
Health Care
Industry
Pharmaceuticals
Teva Pharmaceutical, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Teva Pharmaceutical Indus (TEVA) stock?

A

You can purchase shares of Teva Pharmaceutical Indus (NYSE:TEVA) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Teva Pharmaceutical Indus (TEVA) competitors?

A

There are no as such competitors for Teva Pharmaceutical Indus.

Q

What is the forecast, or price target, for Teva Pharmaceutical Indus (TEVA) stock?

A

Teva Pharmaceutical Indus has a consensus price target of $33.54.

Q

What is the current price for Teva Pharmaceutical Indus (TEVA)?

A

The stock price for Teva Pharmaceutical Indus (NYSE: TEVA) is $34.23 last updated May 22, 2026 at 11:47 AM EDT.

Q

Does Teva Pharmaceutical Indus (TEVA) pay a dividend?

A

There are no upcoming dividends for Teva Pharmaceutical Indus.

Q

When is Teva Pharmaceutical Indus (NYSE:TEVA) reporting earnings?

A

Teva Pharmaceutical Indus does not have any upcoming earnings scheduled.

Q

Is Teva Pharmaceutical Indus (TEVA) going to split?

A

There is no upcoming split for Teva Pharmaceutical Indus.

Q

What sector and industry does Teva Pharmaceutical Indus (TEVA) operate in?

A

Teva Pharmaceutical Indus is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.